<LCTL_TEXT lang="spa">
<DOC grammar="none" id="L0C04CVNI" lang="spa" raw_text_char_length="1481" raw_text_md5="5dcef66ae64f2c6ff692f44d2aef42ef" tokenization="tokenization_parameters.v5.0">
<TEXT>
<SEG end_char="88" id="segment-0" start_char="1">
<ORIGINAL_TEXT>El uso de medicamentos antiinflamatorios no esteroideos (AINE) en pacientes con COVID-19</ORIGINAL_TEXT>
<TOKEN end_char="2" id="token-0-0" morph="none" pos="word" start_char="1">El</TOKEN>
<TOKEN end_char="6" id="token-0-1" morph="none" pos="word" start_char="4">uso</TOKEN>
<TOKEN end_char="9" id="token-0-2" morph="none" pos="word" start_char="8">de</TOKEN>
<TOKEN end_char="22" id="token-0-3" morph="none" pos="word" start_char="11">medicamentos</TOKEN>
<TOKEN end_char="40" id="token-0-4" morph="none" pos="word" start_char="24">antiinflamatorios</TOKEN>
<TOKEN end_char="43" id="token-0-5" morph="none" pos="word" start_char="42">no</TOKEN>
<TOKEN end_char="55" id="token-0-6" morph="none" pos="word" start_char="45">esteroideos</TOKEN>
<TOKEN end_char="57" id="token-0-7" morph="none" pos="punct" start_char="57">(</TOKEN>
<TOKEN end_char="61" id="token-0-8" morph="none" pos="word" start_char="58">AINE</TOKEN>
<TOKEN end_char="62" id="token-0-9" morph="none" pos="punct" start_char="62">)</TOKEN>
<TOKEN end_char="65" id="token-0-10" morph="none" pos="word" start_char="64">en</TOKEN>
<TOKEN end_char="75" id="token-0-11" morph="none" pos="word" start_char="67">pacientes</TOKEN>
<TOKEN end_char="79" id="token-0-12" morph="none" pos="word" start_char="77">con</TOKEN>
<TOKEN end_char="88" id="token-0-13" morph="none" pos="unknown" start_char="81">COVID-19</TOKEN>
<TRANSLATED_TEXT>Use of non-steroidal anti-inflammatory drugs (NSAIDs) in patients with COVID-19</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="234" id="segment-1" start_char="93">
<ORIGINAL_TEXT>Los medicamentos antiinflamatorios no esteroideos (AINE) se encuentran entre los medicamentos más utilizados y tienen una amplia gama de usos.</ORIGINAL_TEXT>
<TOKEN end_char="95" id="token-1-0" morph="none" pos="word" start_char="93">Los</TOKEN>
<TOKEN end_char="108" id="token-1-1" morph="none" pos="word" start_char="97">medicamentos</TOKEN>
<TOKEN end_char="126" id="token-1-2" morph="none" pos="word" start_char="110">antiinflamatorios</TOKEN>
<TOKEN end_char="129" id="token-1-3" morph="none" pos="word" start_char="128">no</TOKEN>
<TOKEN end_char="141" id="token-1-4" morph="none" pos="word" start_char="131">esteroideos</TOKEN>
<TOKEN end_char="143" id="token-1-5" morph="none" pos="punct" start_char="143">(</TOKEN>
<TOKEN end_char="147" id="token-1-6" morph="none" pos="word" start_char="144">AINE</TOKEN>
<TOKEN end_char="148" id="token-1-7" morph="none" pos="punct" start_char="148">)</TOKEN>
<TOKEN end_char="151" id="token-1-8" morph="none" pos="word" start_char="150">se</TOKEN>
<TOKEN end_char="162" id="token-1-9" morph="none" pos="word" start_char="153">encuentran</TOKEN>
<TOKEN end_char="168" id="token-1-10" morph="none" pos="word" start_char="164">entre</TOKEN>
<TOKEN end_char="172" id="token-1-11" morph="none" pos="word" start_char="170">los</TOKEN>
<TOKEN end_char="185" id="token-1-12" morph="none" pos="word" start_char="174">medicamentos</TOKEN>
<TOKEN end_char="189" id="token-1-13" morph="none" pos="word" start_char="187">más</TOKEN>
<TOKEN end_char="200" id="token-1-14" morph="none" pos="word" start_char="191">utilizados</TOKEN>
<TOKEN end_char="202" id="token-1-15" morph="none" pos="word" start_char="202">y</TOKEN>
<TOKEN end_char="209" id="token-1-16" morph="none" pos="word" start_char="204">tienen</TOKEN>
<TOKEN end_char="213" id="token-1-17" morph="none" pos="word" start_char="211">una</TOKEN>
<TOKEN end_char="220" id="token-1-18" morph="none" pos="word" start_char="215">amplia</TOKEN>
<TOKEN end_char="225" id="token-1-19" morph="none" pos="word" start_char="222">gama</TOKEN>
<TOKEN end_char="228" id="token-1-20" morph="none" pos="word" start_char="227">de</TOKEN>
<TOKEN end_char="233" id="token-1-21" morph="none" pos="word" start_char="230">usos</TOKEN>
<TOKEN end_char="234" id="token-1-22" morph="none" pos="punct" start_char="234">.</TOKEN>
<TRANSLATED_TEXT>Non-steroidal anti-inflammatory drugs (NSAIDs) are among the most widely used drugs and have a wide range of uses.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="481" id="segment-2" start_char="236">
<ORIGINAL_TEXT>Los AINE incluyen inhibidores no selectivos de la ciclooxigenasa (COX), como ibuprofeno, aspirina (acetilsalicilato), diclofenaco y naproxeno; así como inhibidores selectivos de COX2 como celecoxib, rofecoxib, etoricoxib, lumiracoxib y valecoxib.</ORIGINAL_TEXT>
<TOKEN end_char="238" id="token-2-0" morph="none" pos="word" start_char="236">Los</TOKEN>
<TOKEN end_char="243" id="token-2-1" morph="none" pos="word" start_char="240">AINE</TOKEN>
<TOKEN end_char="252" id="token-2-2" morph="none" pos="word" start_char="245">incluyen</TOKEN>
<TOKEN end_char="264" id="token-2-3" morph="none" pos="word" start_char="254">inhibidores</TOKEN>
<TOKEN end_char="267" id="token-2-4" morph="none" pos="word" start_char="266">no</TOKEN>
<TOKEN end_char="278" id="token-2-5" morph="none" pos="word" start_char="269">selectivos</TOKEN>
<TOKEN end_char="281" id="token-2-6" morph="none" pos="word" start_char="280">de</TOKEN>
<TOKEN end_char="284" id="token-2-7" morph="none" pos="word" start_char="283">la</TOKEN>
<TOKEN end_char="299" id="token-2-8" morph="none" pos="word" start_char="286">ciclooxigenasa</TOKEN>
<TOKEN end_char="301" id="token-2-9" morph="none" pos="punct" start_char="301">(</TOKEN>
<TOKEN end_char="304" id="token-2-10" morph="none" pos="word" start_char="302">COX</TOKEN>
<TOKEN end_char="306" id="token-2-11" morph="none" pos="punct" start_char="305">),</TOKEN>
<TOKEN end_char="311" id="token-2-12" morph="none" pos="word" start_char="308">como</TOKEN>
<TOKEN end_char="322" id="token-2-13" morph="none" pos="word" start_char="313">ibuprofeno</TOKEN>
<TOKEN end_char="323" id="token-2-14" morph="none" pos="punct" start_char="323">,</TOKEN>
<TOKEN end_char="332" id="token-2-15" morph="none" pos="word" start_char="325">aspirina</TOKEN>
<TOKEN end_char="334" id="token-2-16" morph="none" pos="punct" start_char="334">(</TOKEN>
<TOKEN end_char="350" id="token-2-17" morph="none" pos="word" start_char="335">acetilsalicilato</TOKEN>
<TOKEN end_char="352" id="token-2-18" morph="none" pos="punct" start_char="351">),</TOKEN>
<TOKEN end_char="364" id="token-2-19" morph="none" pos="word" start_char="354">diclofenaco</TOKEN>
<TOKEN end_char="366" id="token-2-20" morph="none" pos="word" start_char="366">y</TOKEN>
<TOKEN end_char="376" id="token-2-21" morph="none" pos="word" start_char="368">naproxeno</TOKEN>
<TOKEN end_char="377" id="token-2-22" morph="none" pos="punct" start_char="377">;</TOKEN>
<TOKEN end_char="381" id="token-2-23" morph="none" pos="word" start_char="379">así</TOKEN>
<TOKEN end_char="386" id="token-2-24" morph="none" pos="word" start_char="383">como</TOKEN>
<TOKEN end_char="398" id="token-2-25" morph="none" pos="word" start_char="388">inhibidores</TOKEN>
<TOKEN end_char="409" id="token-2-26" morph="none" pos="word" start_char="400">selectivos</TOKEN>
<TOKEN end_char="412" id="token-2-27" morph="none" pos="word" start_char="411">de</TOKEN>
<TOKEN end_char="417" id="token-2-28" morph="none" pos="word" start_char="414">COX2</TOKEN>
<TOKEN end_char="422" id="token-2-29" morph="none" pos="word" start_char="419">como</TOKEN>
<TOKEN end_char="432" id="token-2-30" morph="none" pos="word" start_char="424">celecoxib</TOKEN>
<TOKEN end_char="433" id="token-2-31" morph="none" pos="punct" start_char="433">,</TOKEN>
<TOKEN end_char="443" id="token-2-32" morph="none" pos="word" start_char="435">rofecoxib</TOKEN>
<TOKEN end_char="444" id="token-2-33" morph="none" pos="punct" start_char="444">,</TOKEN>
<TOKEN end_char="455" id="token-2-34" morph="none" pos="word" start_char="446">etoricoxib</TOKEN>
<TOKEN end_char="456" id="token-2-35" morph="none" pos="punct" start_char="456">,</TOKEN>
<TOKEN end_char="468" id="token-2-36" morph="none" pos="word" start_char="458">lumiracoxib</TOKEN>
<TOKEN end_char="470" id="token-2-37" morph="none" pos="word" start_char="470">y</TOKEN>
<TOKEN end_char="480" id="token-2-38" morph="none" pos="word" start_char="472">valecoxib</TOKEN>
<TOKEN end_char="481" id="token-2-39" morph="none" pos="punct" start_char="481">.</TOKEN>
<TRANSLATED_TEXT>NSAIDs include non-selective cyclooxygenase (COX) inhibitors such as ibuprofen, aspirin (acetylsalicylate), diclofenac, and naproxen; as well as selective COX2 inhibitors such as celecoxib, rofecoxib, etoricoxib, lumiracoxib, and valecoxib.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="690" id="segment-3" start_char="484">
<ORIGINAL_TEXT>Se ha planteado la preocupación de que los AINE pueden estar asociados con un mayor riesgo de efectos adversos cuando se utilizan en pacientes con infecciones respiratorias virales agudas, incluido COVID-19.</ORIGINAL_TEXT>
<TOKEN end_char="485" id="token-3-0" morph="none" pos="word" start_char="484">Se</TOKEN>
<TOKEN end_char="488" id="token-3-1" morph="none" pos="word" start_char="487">ha</TOKEN>
<TOKEN end_char="498" id="token-3-2" morph="none" pos="word" start_char="490">planteado</TOKEN>
<TOKEN end_char="501" id="token-3-3" morph="none" pos="word" start_char="500">la</TOKEN>
<TOKEN end_char="514" id="token-3-4" morph="none" pos="word" start_char="503">preocupación</TOKEN>
<TOKEN end_char="517" id="token-3-5" morph="none" pos="word" start_char="516">de</TOKEN>
<TOKEN end_char="521" id="token-3-6" morph="none" pos="word" start_char="519">que</TOKEN>
<TOKEN end_char="525" id="token-3-7" morph="none" pos="word" start_char="523">los</TOKEN>
<TOKEN end_char="530" id="token-3-8" morph="none" pos="word" start_char="527">AINE</TOKEN>
<TOKEN end_char="537" id="token-3-9" morph="none" pos="word" start_char="532">pueden</TOKEN>
<TOKEN end_char="543" id="token-3-10" morph="none" pos="word" start_char="539">estar</TOKEN>
<TOKEN end_char="553" id="token-3-11" morph="none" pos="word" start_char="545">asociados</TOKEN>
<TOKEN end_char="557" id="token-3-12" morph="none" pos="word" start_char="555">con</TOKEN>
<TOKEN end_char="560" id="token-3-13" morph="none" pos="word" start_char="559">un</TOKEN>
<TOKEN end_char="566" id="token-3-14" morph="none" pos="word" start_char="562">mayor</TOKEN>
<TOKEN end_char="573" id="token-3-15" morph="none" pos="word" start_char="568">riesgo</TOKEN>
<TOKEN end_char="576" id="token-3-16" morph="none" pos="word" start_char="575">de</TOKEN>
<TOKEN end_char="584" id="token-3-17" morph="none" pos="word" start_char="578">efectos</TOKEN>
<TOKEN end_char="593" id="token-3-18" morph="none" pos="word" start_char="586">adversos</TOKEN>
<TOKEN end_char="600" id="token-3-19" morph="none" pos="word" start_char="595">cuando</TOKEN>
<TOKEN end_char="603" id="token-3-20" morph="none" pos="word" start_char="602">se</TOKEN>
<TOKEN end_char="612" id="token-3-21" morph="none" pos="word" start_char="605">utilizan</TOKEN>
<TOKEN end_char="615" id="token-3-22" morph="none" pos="word" start_char="614">en</TOKEN>
<TOKEN end_char="625" id="token-3-23" morph="none" pos="word" start_char="617">pacientes</TOKEN>
<TOKEN end_char="629" id="token-3-24" morph="none" pos="word" start_char="627">con</TOKEN>
<TOKEN end_char="641" id="token-3-25" morph="none" pos="word" start_char="631">infecciones</TOKEN>
<TOKEN end_char="655" id="token-3-26" morph="none" pos="word" start_char="643">respiratorias</TOKEN>
<TOKEN end_char="663" id="token-3-27" morph="none" pos="word" start_char="657">virales</TOKEN>
<TOKEN end_char="670" id="token-3-28" morph="none" pos="word" start_char="665">agudas</TOKEN>
<TOKEN end_char="671" id="token-3-29" morph="none" pos="punct" start_char="671">,</TOKEN>
<TOKEN end_char="680" id="token-3-30" morph="none" pos="word" start_char="673">incluido</TOKEN>
<TOKEN end_char="689" id="token-3-31" morph="none" pos="unknown" start_char="682">COVID-19</TOKEN>
<TOKEN end_char="690" id="token-3-32" morph="none" pos="punct" start_char="690">.</TOKEN>
<TRANSLATED_TEXT>Concern has been raised that NSAIDs may be associated with an increased risk of adverse effects when used in patients with acute viral respiratory infections, including COVID-19.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="1264" id="segment-4" start_char="693">
<ORIGINAL_TEXT>Esta revisión tuvo como objetivo evaluar los efectos del uso previo y actual de AINE en pacientes con infecciones agudas infecciones respiratorias virales en eventos adversos graves agudos, incluida la mortalidad, el síndrome de dificultad respiratoria aguda (SDRA), insuficiencia orgánica aguda e infecciones oportunistas; en la utilización de atención médica aguda, incluida la hospitalización, ingreso en la unidad de cuidados intensivos (UCI), terapia de oxígeno suplementario y ventilación mecánica; así como sobre la calidad de vida y la supervivencia a largo plazo.</ORIGINAL_TEXT>
<TOKEN end_char="696" id="token-4-0" morph="none" pos="word" start_char="693">Esta</TOKEN>
<TOKEN end_char="705" id="token-4-1" morph="none" pos="word" start_char="698">revisión</TOKEN>
<TOKEN end_char="710" id="token-4-2" morph="none" pos="word" start_char="707">tuvo</TOKEN>
<TOKEN end_char="715" id="token-4-3" morph="none" pos="word" start_char="712">como</TOKEN>
<TOKEN end_char="724" id="token-4-4" morph="none" pos="word" start_char="717">objetivo</TOKEN>
<TOKEN end_char="732" id="token-4-5" morph="none" pos="word" start_char="726">evaluar</TOKEN>
<TOKEN end_char="736" id="token-4-6" morph="none" pos="word" start_char="734">los</TOKEN>
<TOKEN end_char="744" id="token-4-7" morph="none" pos="word" start_char="738">efectos</TOKEN>
<TOKEN end_char="748" id="token-4-8" morph="none" pos="word" start_char="746">del</TOKEN>
<TOKEN end_char="752" id="token-4-9" morph="none" pos="word" start_char="750">uso</TOKEN>
<TOKEN end_char="759" id="token-4-10" morph="none" pos="word" start_char="754">previo</TOKEN>
<TOKEN end_char="761" id="token-4-11" morph="none" pos="word" start_char="761">y</TOKEN>
<TOKEN end_char="768" id="token-4-12" morph="none" pos="word" start_char="763">actual</TOKEN>
<TOKEN end_char="771" id="token-4-13" morph="none" pos="word" start_char="770">de</TOKEN>
<TOKEN end_char="776" id="token-4-14" morph="none" pos="word" start_char="773">AINE</TOKEN>
<TOKEN end_char="779" id="token-4-15" morph="none" pos="word" start_char="778">en</TOKEN>
<TOKEN end_char="789" id="token-4-16" morph="none" pos="word" start_char="781">pacientes</TOKEN>
<TOKEN end_char="793" id="token-4-17" morph="none" pos="word" start_char="791">con</TOKEN>
<TOKEN end_char="805" id="token-4-18" morph="none" pos="word" start_char="795">infecciones</TOKEN>
<TOKEN end_char="812" id="token-4-19" morph="none" pos="word" start_char="807">agudas</TOKEN>
<TOKEN end_char="824" id="token-4-20" morph="none" pos="word" start_char="814">infecciones</TOKEN>
<TOKEN end_char="838" id="token-4-21" morph="none" pos="word" start_char="826">respiratorias</TOKEN>
<TOKEN end_char="846" id="token-4-22" morph="none" pos="word" start_char="840">virales</TOKEN>
<TOKEN end_char="849" id="token-4-23" morph="none" pos="word" start_char="848">en</TOKEN>
<TOKEN end_char="857" id="token-4-24" morph="none" pos="word" start_char="851">eventos</TOKEN>
<TOKEN end_char="866" id="token-4-25" morph="none" pos="word" start_char="859">adversos</TOKEN>
<TOKEN end_char="873" id="token-4-26" morph="none" pos="word" start_char="868">graves</TOKEN>
<TOKEN end_char="880" id="token-4-27" morph="none" pos="word" start_char="875">agudos</TOKEN>
<TOKEN end_char="881" id="token-4-28" morph="none" pos="punct" start_char="881">,</TOKEN>
<TOKEN end_char="890" id="token-4-29" morph="none" pos="word" start_char="883">incluida</TOKEN>
<TOKEN end_char="893" id="token-4-30" morph="none" pos="word" start_char="892">la</TOKEN>
<TOKEN end_char="904" id="token-4-31" morph="none" pos="word" start_char="895">mortalidad</TOKEN>
<TOKEN end_char="905" id="token-4-32" morph="none" pos="punct" start_char="905">,</TOKEN>
<TOKEN end_char="908" id="token-4-33" morph="none" pos="word" start_char="907">el</TOKEN>
<TOKEN end_char="917" id="token-4-34" morph="none" pos="word" start_char="910">síndrome</TOKEN>
<TOKEN end_char="920" id="token-4-35" morph="none" pos="word" start_char="919">de</TOKEN>
<TOKEN end_char="931" id="token-4-36" morph="none" pos="word" start_char="922">dificultad</TOKEN>
<TOKEN end_char="944" id="token-4-37" morph="none" pos="word" start_char="933">respiratoria</TOKEN>
<TOKEN end_char="950" id="token-4-38" morph="none" pos="word" start_char="946">aguda</TOKEN>
<TOKEN end_char="952" id="token-4-39" morph="none" pos="punct" start_char="952">(</TOKEN>
<TOKEN end_char="956" id="token-4-40" morph="none" pos="word" start_char="953">SDRA</TOKEN>
<TOKEN end_char="958" id="token-4-41" morph="none" pos="punct" start_char="957">),</TOKEN>
<TOKEN end_char="972" id="token-4-42" morph="none" pos="word" start_char="960">insuficiencia</TOKEN>
<TOKEN end_char="981" id="token-4-43" morph="none" pos="word" start_char="974">orgánica</TOKEN>
<TOKEN end_char="987" id="token-4-44" morph="none" pos="word" start_char="983">aguda</TOKEN>
<TOKEN end_char="989" id="token-4-45" morph="none" pos="word" start_char="989">e</TOKEN>
<TOKEN end_char="1001" id="token-4-46" morph="none" pos="word" start_char="991">infecciones</TOKEN>
<TOKEN end_char="1014" id="token-4-47" morph="none" pos="word" start_char="1003">oportunistas</TOKEN>
<TOKEN end_char="1015" id="token-4-48" morph="none" pos="punct" start_char="1015">;</TOKEN>
<TOKEN end_char="1018" id="token-4-49" morph="none" pos="word" start_char="1017">en</TOKEN>
<TOKEN end_char="1021" id="token-4-50" morph="none" pos="word" start_char="1020">la</TOKEN>
<TOKEN end_char="1033" id="token-4-51" morph="none" pos="word" start_char="1023">utilización</TOKEN>
<TOKEN end_char="1036" id="token-4-52" morph="none" pos="word" start_char="1035">de</TOKEN>
<TOKEN end_char="1045" id="token-4-53" morph="none" pos="word" start_char="1038">atención</TOKEN>
<TOKEN end_char="1052" id="token-4-54" morph="none" pos="word" start_char="1047">médica</TOKEN>
<TOKEN end_char="1058" id="token-4-55" morph="none" pos="word" start_char="1054">aguda</TOKEN>
<TOKEN end_char="1059" id="token-4-56" morph="none" pos="punct" start_char="1059">,</TOKEN>
<TOKEN end_char="1068" id="token-4-57" morph="none" pos="word" start_char="1061">incluida</TOKEN>
<TOKEN end_char="1071" id="token-4-58" morph="none" pos="word" start_char="1070">la</TOKEN>
<TOKEN end_char="1087" id="token-4-59" morph="none" pos="word" start_char="1073">hospitalización</TOKEN>
<TOKEN end_char="1088" id="token-4-60" morph="none" pos="punct" start_char="1088">,</TOKEN>
<TOKEN end_char="1096" id="token-4-61" morph="none" pos="word" start_char="1090">ingreso</TOKEN>
<TOKEN end_char="1099" id="token-4-62" morph="none" pos="word" start_char="1098">en</TOKEN>
<TOKEN end_char="1102" id="token-4-63" morph="none" pos="word" start_char="1101">la</TOKEN>
<TOKEN end_char="1109" id="token-4-64" morph="none" pos="word" start_char="1104">unidad</TOKEN>
<TOKEN end_char="1112" id="token-4-65" morph="none" pos="word" start_char="1111">de</TOKEN>
<TOKEN end_char="1121" id="token-4-66" morph="none" pos="word" start_char="1114">cuidados</TOKEN>
<TOKEN end_char="1132" id="token-4-67" morph="none" pos="word" start_char="1123">intensivos</TOKEN>
<TOKEN end_char="1134" id="token-4-68" morph="none" pos="punct" start_char="1134">(</TOKEN>
<TOKEN end_char="1137" id="token-4-69" morph="none" pos="word" start_char="1135">UCI</TOKEN>
<TOKEN end_char="1139" id="token-4-70" morph="none" pos="punct" start_char="1138">),</TOKEN>
<TOKEN end_char="1147" id="token-4-71" morph="none" pos="word" start_char="1141">terapia</TOKEN>
<TOKEN end_char="1150" id="token-4-72" morph="none" pos="word" start_char="1149">de</TOKEN>
<TOKEN end_char="1158" id="token-4-73" morph="none" pos="word" start_char="1152">oxígeno</TOKEN>
<TOKEN end_char="1172" id="token-4-74" morph="none" pos="word" start_char="1160">suplementario</TOKEN>
<TOKEN end_char="1174" id="token-4-75" morph="none" pos="word" start_char="1174">y</TOKEN>
<TOKEN end_char="1186" id="token-4-76" morph="none" pos="word" start_char="1176">ventilación</TOKEN>
<TOKEN end_char="1195" id="token-4-77" morph="none" pos="word" start_char="1188">mecánica</TOKEN>
<TOKEN end_char="1196" id="token-4-78" morph="none" pos="punct" start_char="1196">;</TOKEN>
<TOKEN end_char="1200" id="token-4-79" morph="none" pos="word" start_char="1198">así</TOKEN>
<TOKEN end_char="1205" id="token-4-80" morph="none" pos="word" start_char="1202">como</TOKEN>
<TOKEN end_char="1211" id="token-4-81" morph="none" pos="word" start_char="1207">sobre</TOKEN>
<TOKEN end_char="1214" id="token-4-82" morph="none" pos="word" start_char="1213">la</TOKEN>
<TOKEN end_char="1222" id="token-4-83" morph="none" pos="word" start_char="1216">calidad</TOKEN>
<TOKEN end_char="1225" id="token-4-84" morph="none" pos="word" start_char="1224">de</TOKEN>
<TOKEN end_char="1230" id="token-4-85" morph="none" pos="word" start_char="1227">vida</TOKEN>
<TOKEN end_char="1232" id="token-4-86" morph="none" pos="word" start_char="1232">y</TOKEN>
<TOKEN end_char="1235" id="token-4-87" morph="none" pos="word" start_char="1234">la</TOKEN>
<TOKEN end_char="1249" id="token-4-88" morph="none" pos="word" start_char="1237">supervivencia</TOKEN>
<TOKEN end_char="1251" id="token-4-89" morph="none" pos="word" start_char="1251">a</TOKEN>
<TOKEN end_char="1257" id="token-4-90" morph="none" pos="word" start_char="1253">largo</TOKEN>
<TOKEN end_char="1263" id="token-4-91" morph="none" pos="word" start_char="1259">plazo</TOKEN>
<TOKEN end_char="1264" id="token-4-92" morph="none" pos="punct" start_char="1264">.</TOKEN>
<TRANSLATED_TEXT>The objective of this review was to evaluate the effects of previous and current use of NSAID in patients with acute viral respiratory infections on acute serious adverse events, including mortality, acute respiratory difficulty syndrome (SDRA), acute organic insufficiency and opportunistic infections; on the use of acute health care, including hospitalization, admission to the intensive care unit (ICU), supplemental oxygen therapy and mechanical ventilation; and on quality of life and long-term survival.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="1288" id="segment-5" start_char="1267">
<ORIGINAL_TEXT>Vea el texto completo.</ORIGINAL_TEXT>
<TOKEN end_char="1269" id="token-5-0" morph="none" pos="word" start_char="1267">Vea</TOKEN>
<TOKEN end_char="1272" id="token-5-1" morph="none" pos="word" start_char="1271">el</TOKEN>
<TOKEN end_char="1278" id="token-5-2" morph="none" pos="word" start_char="1274">texto</TOKEN>
<TOKEN end_char="1287" id="token-5-3" morph="none" pos="word" start_char="1280">completo</TOKEN>
<TOKEN end_char="1288" id="token-5-4" morph="none" pos="punct" start_char="1288">.</TOKEN>
<TRANSLATED_TEXT>See the full text.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="1313" id="segment-6" start_char="1291">
<ORIGINAL_TEXT>Descargar pdf (180 Kb):</ORIGINAL_TEXT>
<TOKEN end_char="1299" id="token-6-0" morph="none" pos="word" start_char="1291">Descargar</TOKEN>
<TOKEN end_char="1303" id="token-6-1" morph="none" pos="word" start_char="1301">pdf</TOKEN>
<TOKEN end_char="1305" id="token-6-2" morph="none" pos="punct" start_char="1305">(</TOKEN>
<TOKEN end_char="1308" id="token-6-3" morph="none" pos="word" start_char="1306">180</TOKEN>
<TOKEN end_char="1311" id="token-6-4" morph="none" pos="word" start_char="1310">Kb</TOKEN>
<TOKEN end_char="1313" id="token-6-5" morph="none" pos="punct" start_char="1312">):</TOKEN>
<TRANSLATED_TEXT>Download pdf (180 Kb):</TRANSLATED_TEXT><DETECTED_LANGUAGE>id</DETECTED_LANGUAGE></SEG>
<SEG end_char="1417" id="segment-7" start_char="1316">
<ORIGINAL_TEXT>The use of non-steroidal anti-inflammatory drugs (NSAIDs) in patients with COVID-19: Scientific brief.</ORIGINAL_TEXT>
<TOKEN end_char="1318" id="token-7-0" morph="none" pos="word" start_char="1316">The</TOKEN>
<TOKEN end_char="1322" id="token-7-1" morph="none" pos="word" start_char="1320">use</TOKEN>
<TOKEN end_char="1325" id="token-7-2" morph="none" pos="word" start_char="1324">of</TOKEN>
<TOKEN end_char="1339" id="token-7-3" morph="none" pos="unknown" start_char="1327">non-steroidal</TOKEN>
<TOKEN end_char="1357" id="token-7-4" morph="none" pos="unknown" start_char="1341">anti-inflammatory</TOKEN>
<TOKEN end_char="1363" id="token-7-5" morph="none" pos="word" start_char="1359">drugs</TOKEN>
<TOKEN end_char="1365" id="token-7-6" morph="none" pos="punct" start_char="1365">(</TOKEN>
<TOKEN end_char="1371" id="token-7-7" morph="none" pos="word" start_char="1366">NSAIDs</TOKEN>
<TOKEN end_char="1372" id="token-7-8" morph="none" pos="punct" start_char="1372">)</TOKEN>
<TOKEN end_char="1375" id="token-7-9" morph="none" pos="word" start_char="1374">in</TOKEN>
<TOKEN end_char="1384" id="token-7-10" morph="none" pos="word" start_char="1377">patients</TOKEN>
<TOKEN end_char="1389" id="token-7-11" morph="none" pos="word" start_char="1386">with</TOKEN>
<TOKEN end_char="1398" id="token-7-12" morph="none" pos="unknown" start_char="1391">COVID-19</TOKEN>
<TOKEN end_char="1399" id="token-7-13" morph="none" pos="punct" start_char="1399">:</TOKEN>
<TOKEN end_char="1410" id="token-7-14" morph="none" pos="word" start_char="1401">Scientific</TOKEN>
<TOKEN end_char="1416" id="token-7-15" morph="none" pos="word" start_char="1412">brief</TOKEN>
<TOKEN end_char="1417" id="token-7-16" morph="none" pos="punct" start_char="1417">.</TOKEN>
</SEG>
<SEG end_char="1477" id="segment-8" start_char="1419">
<ORIGINAL_TEXT>WHO reference number: WHO/2019-nCoV/Sci_Brief/NSAIDs/2020.1</ORIGINAL_TEXT>
<TOKEN end_char="1421" id="token-8-0" morph="none" pos="word" start_char="1419">WHO</TOKEN>
<TOKEN end_char="1431" id="token-8-1" morph="none" pos="word" start_char="1423">reference</TOKEN>
<TOKEN end_char="1438" id="token-8-2" morph="none" pos="word" start_char="1433">number</TOKEN>
<TOKEN end_char="1439" id="token-8-3" morph="none" pos="punct" start_char="1439">:</TOKEN>
<TOKEN end_char="1477" id="token-8-4" morph="none" pos="unknown" start_char="1441">WHO/2019-nCoV/Sci_Brief/NSAIDs/2020.1</TOKEN>
</SEG>
</TEXT>
</DOC>
</LCTL_TEXT>